Hawthorn 1050 mg

Hawthorn 1050 mg

Solaray4.7 (3,199 ratings)
Format:Capsule Quantity: 180 VegCap(s) · 90 servings
Goals
$18.06 $0.20 per serving

Product analysis

63 out of 100

Hawthorn 1050 mg offers a simple, low-cost hawthorn supplement for people interested in heart support. Findings depend on specific extracts, so they do not establish the same benefit from this unspecified preparation.

AI assessment of the formula, label and price. How scoring works

Nutrient Quality20

The hawthorn preparation is unspecified. That matters because heart-related findings concern particular, carefully defined extracts.

Ingredient Transparency63

The hawthorn quantity is stated, making servings easy to compare by weight. The preparation is not identified, limiting closer comparisons with specific extracts.

Value For Money100

The labeled serving compares very favorably on cost. The low cost does not establish equivalence to the specific hawthorn extracts behind clinical findings.

Customer Satisfaction87

Customer feedback is strongly positive across a large review base. The number of reviews makes the satisfaction pattern less dependent on a few opinions.

Product Focus73

The single-herb formula stays closely focused on heart-related interest. Clinical findings are conflicting and preparation-specific, so routine benefits remain uncertain.

Format
Capsule
Container
180 VegCap(s)
Per serving
$0.20
Customer rating
4.7 · 3,199 ratings
Report analysis

Goals

Heart Health
Impact
High effect
A+ Ingredient FitD- PathwaysC+ EvidenceA+ Formulation Logic
Study evidence
Hawthorn Supportive 27 studies
Cardiovascular Support
Impact
Highest effect
A+ Ingredient FitC- PathwaysB+ EvidenceA+ Formulation Logic
Hawthorn · 1050 mg
Study evidence
Hawthorn Supportive 28 studies

Ingredients

IngredientAmount per servingScore
Hawthorn
1050 mg 52
Adults 18–50 Vegan Dairy Free Vegetarian
Report overview
Hawthorn · 1050 mg OverallScore52
F Composition And Label DisclosureA+ Commercial Price And Usability
The serving provides 1050 mg of hawthorn, with a lower whole-product cost per serving. No marker concentration or preparation ratio is available. The hawthorn species is not specified in the available information.
How this ingredient is rated

Composition and Label Disclosure29

No marker concentration or preparation ratio is available. The hawthorn species is not specified in the available information.
Marker and Preparation Disclosure
No marker concentration or preparation ratio is available.
Species Name Disclosure
The hawthorn species is not specified in the available information.

Composition and Label Disclosure

No separate preparation or amount details are evaluated in this group.

Commercial Price and Usability100

The whole-product cost per serving is lower.
Commercial Price per Labeled Serving
The whole-product cost per serving is lower.
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Real world effectiveness of Hawthorn special extract WS 1442 in a retrospective cohort study from Germany.
    Wyss C; Gündling PW; Kostev K · Scientific reports · 2024
    Cohort study9,100 participantsCardiovascular Support forHawthorn
  2. Hawthorn (Crataegus spp.) Clinically Significantly Reduces Blood Pressure in Hypertension: A Meta-Analysis of Randomized Placebo-Controlled Clinical Trials.
    Szikora Z; Mátyus RO; Szabó BV; Csupor D; Tóth B · Pharmaceuticals (Basel, Switzerland) · 2025
    Meta-analysis428 participants6 studies pooledCardiovascular Support Heart Health forHawthorn
  3. A randomised double blind placebo controlled clinical trial of a standardised extract of fresh Crataegus berries (Crataegisan) in the treatment of patients with congestive heart failure NYHA II.
    Degenring FH; Suter A; Weber M; Saller R · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2003
    Randomized trial143 participantsCardiovascular Support forHawthorn
  4. [Crataegus Special Extract WS 1442. Assessment of objective effectiveness in patients with heart failure (NYHA II)].
    Weikl A; Assmus KD; Neukum-Schmidt A; Schmitz J; Zapfe G; Noh HS; Siegrist J · Fortschritte der Medizin · 1996
    Randomized trial136 participantsCardiovascular Support forHawthorn
  5. Prospective, comparative cohort studies and their contribution to the benefit assessments of therapeutic options: heart failure treatment with and without Hawthorn special extract WS 1442.
    Habs M · Forschende Komplementarmedizin und klassische Naturheilkunde = Research in complementary and natural classical medicine · 2005
    Cohort study952 participantsCardiovascular Support forHawthorn
  6. [Actions of standardized extracts of Crataegus berries on exercise tolerance and quality of life in patients with congestive heart failure].
    Rietbrock N; Hamel M; Hempel B; Mitrovic V; Schmidt T; Wolf GK · Arzneimittel-Forschung · 2001
    Randomized trial88 participantsHeart Health forHawthorn
  7. Hawthorn extract for treating chronic heart failure: meta-analysis of randomized trials.
    Pittler MH; Schmidt K; Ernst E · The American journal of medicine · 2003
    Meta-analysis632 participants13 studies pooledHeart Health forHawthorn
  8. Clinical efficacy of crataegus extract WS 1442 in congestive heart failure NYHA class II.
    Zapfe jun G · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2002
    Randomized trial40 participantsHeart Health forHawthorn
  9. Baseline severity but not gender modulates quantified Crataegus extract effects in early heart failure--a pooled analysis of clinical trials.
    Eggeling T; Regitz-Zagrosek V; Zimmermann A; Burkart M · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2012
    Meta-analysis687 participants10 studies pooledHeart Health forHawthorn